Binding of Wheat Gliadin in Vitro to Reticulin in Normal and Dermatitis Herpetiformis Skin  by Unsworth, D.J. et al.
0022-202X/ 81 /7602-0088$02.00/ 0 
THE JOURNAL OF INVESTIGATIVE DERMATOLOGY, 76:88-93 , 1981 
Copyright © 1981 by The Willia ms & Wilkins Co. 
\'ol. 76. No . 2 
Printed in L'. S.A. 
Binding of Wheat Gliadin in Vitro to Reticulin in Normal and Dermatitis 
Herpetiformis Skin 
D. J. UNSWORTH, BSC, G. D. JOHNSON, PH.D. MRCPATH., G. HAFFENDEN, FIMLS, L. FRY, M.D. FRCP., AND 
E. J. HOLBOROW, M.D. FRCP FRCPATH. 
Department of Dermatology, St. Mary 's Hospital (GH & LF) ?addington, England 
We have demonstrated by indirect immunofluores-
cence that wheat gliadin binds in vitro to reticulin-like 
fibrils present in cryostat sections of human skin, and 
rat liver, kidney and stomach. 
Gliadin was seen to bind to fibrils throughout the 
dermis of both normal and dermatitis herpetiformis skin, 
and this was particularly striking in the dermal papillae. 
Serum from 2 dermatitis herpetiformis patients who did 
not have antireticulin antibody gave reticulin staining 
when retested by immunofluorescence on cryostat sec-
tions of rat tissue pretreated with gliadin. Gliadin 
treated sections may prove useful in screening patients 
with gluten sensitive enteropathy for anti-gliadin anti-
body. Binding of gliadin to skin sites in dermatitis 
herpetiformis patients and subsequent deposition of an-
tigliadin antibody at these sites may be involved in the 
development of skin lesions. 
Circulating antibodies to reticulin (1 , 2) are present in 15-
20% of dermatitis herpetiformis (DH) patients, and tend to 
disappear when a gluten-free diet (GFD) is established (2, 3). 
Antibodies to wheat_glia9in may also be present [ 4). It has been 
proposed [5) that these antibodies may account for the IgA 
deposits (granular or linear), characteristically present in DH 
skin [6, 7). 
While investigating the possible immunological cross reactiv-
ity of wheat gluten and reticulin suggested by Seah et al (3) , we 
observed that aqueous preparations of wheat gliadin displayed 
a striking affinity for reticulin fibers in cryostat sections of rat 
tissue. We have studied the binding of such aqueous prepara-
tions of gliadin to human skin sections, and report here that 
gliadin binds to reticulin-like fibrils in the dermis of both normal 
and DH skin. 
PATIENTS AND METHODS 
Patients 
A diagnosis of DH was based on the clinical features, the response of 
the rash to Dapsone, and on the presence of IgA deposits in biopsies of 
uninvolved skin. P unch biopsies from uninvolved skin of 8 DH patients 
and from the fo rearm of 5 healthy control subjects, were taken under 
local anesthetic, embedded in OCT medium (Miles Laboratories Inc.) 
and frozen in liquid nitrogen cooled isopentane before storage at -70°C. 
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Abbreviations: 
AGA: anti-gliadin antibody 
ARA: anti-reticulin antibody 
DH: dermatitis herpetiformis 
FITC: Fluorescein iso-thiocyanate 
GFD: glu ten-free diet 
IF: immunofluorescence 
PBS: phosphate buffered saline 
IgA deposits were demonstrated in. the dermis of all 8 DH patients by 
di.rect immunofluorescence (IF) on cryostat sections (6 Jl) of skin. In 7 
of these patients the deposits were microgranular, and in 1 patient a 
linear deposition of lgA immediately below thP. basement membrane 
was seen. Complement (C3) deposits accompanied the granular l gA in 
the skin of 5 DH patients. No IgA or C3 deposits were seen in skin 
biopsies from control subj ects. S ix of the 8 DH patients were being 
treated with Dapsone, 1 patient with a strict GFD, and 1 patient was 
in remission and untreated. 
Materials 
Fraction III was prepared as described by Frazer eta! [8] from wheat 
gluten (Sigma Chemicals). Crude gliadin was prepared from "Flanders," 
a variety of wheat flour grown in UK by the method described by 
Ewart [9], and freeze dried. The expected range of a, {3, y and w gliadins 
(approximately 20 bands), and a wheat albumin band, were shown to 
be present by polyacrylamide gel electrophoresis [10]. A single a gliadin 
purified from Maris Huntsman wheat flour , free of wheat albumin and 
other gliadins was kindly donated by Mr. J . Sargeant. Crude Flanders 
gliad in (10 mg/ml of distilled water) was labeled with fluorescein iso-
thiocyanate isomer 1 (FITCl (British Drug Houses). FITC (50 Jlg/ mg 
protein) was dissolved in 1 vol of 0.5 Molar carbonate-bicarbonate 
buffer pH 9.5 [11], and added to 9 vol of aqueous crude gliadin. Labeling 
was a llowed to cont inu e for 2 hr at room temperature, and free FITC 
removed by overnight dialysis (with several changes) aga inst distilled 
water. This FITC labeled crude gliadin had an optical density ratio (495 
nm:280 nm) of 1.25:1.00. 
A noncollagenous reticulin component (NCRC) of human spleen was 
prepared as described by Pras and Glynn [1 2], and rabbit antisera to 
human NCRC were prepared as described previously [1 3]. Rabbit 
antisera to crude Flanders gliadin were raised in New Zealand White 
rabbits by a subcutaneous injection of 2 mg of crude Flanders gliadin 
emulsified in Freund's complete adjuvant. The rabbits were boosted 
after 1 mo by intraperitoneal inj ect ion of 1 mg of crude gliadin in 
distilled water, and bled after a further week. The titre of rabbit anti-
gliadin ant ibody (AGA) was estimated by passive hemagglutination of 
gliadin-coated tanned sheep erythrocytes [14), and these rabbit AGA 
were shown to react with a range of gluten proteins (including Frazer's 
fraction III , crude gliadin and a gliadin) by the ELISA technique [15]. 
The titre of rabbit anti-human NCRC was esti.mated by indi.rect im-
munofluorescence on cryostat sections of ra t tissue [11]. 
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Immunofluorescence (IF) 
Ci.rculating autoan tibodies including anti-reticulin antibody (ARA) 
in patients' sera, were detected as described previously [11]. Serum 
samples were only considered positive for ARA when the characteristic 
reticulin staining pattern defined as "R," by Rizetto and Doniach [16) 
was seen. 
Gliadin binding to cryostat sections of rat kidney, liver and stomach 
was demonstrated di.rectly using FITC labeled gliadin. Alternatively, 
gliadin binding could be demonstrated indi.rectly using AGA. Cryostat 
sect ions of rat tissue , or of human skin were incubated for 30 min with 
an aqueous solution of crude gliadin oo· ' mg/ ml), and unbound protein 
was washed off in phosphate buffered saline (PBS) for 30 min. The 
gliadin pretreated sections were incubated with rabbit AGA or with 
patients' sera for 30 min, washed in PBS for 30 min, and then incubated 
with species specific flu orescein-labeled antiglobulin as the final step. 
Gliadin pretreated sect ions incubated with noni.mmune rabbit sera 
or normal human sera and sections incubated with distilled water in 
place of aqueous gliadin were included as controls. Gliadin bindi.ng 
experiments were repeated using gliadin prepared in PBS or in normal 
rabbit serum (at 10- ' mg/ ml) rather than in distilled water, to determine 
whether or not gliadin binding could be demonstrated using saline 
preparations of gliadin. Attempts to demonstrate in uiuo bound gliadin 
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by indirect IF used several different rabbi t ant isera to gliadin as the 
frrst step , fo llowed by FITC conjugated sheep anti-rabbi t immunoglob-
ulin (lg) . Skin ret iculin was ident ified in parallel sections by the silver 
impregnation method (1 7], and by indirect IF using ra bbi t ant i-human 
CRC. FITC conjugated sheep ant ibodies against lgM, lgG, lgA, C3, 
Ig (polyvalent), and rabbi t lg (polyvalent ), with fluorescein/ protein 
(molar ) ratios ranging from 3.1 to 4.1 were supplied by Wellcome 
Reagents, and used at working dilu t ions determined by block titration 
[ll). 
S lides were examined on a Reichert microscope equipped with a 
100 w quartz halogen lamp, and dark ground condenser. The primary 
fil ter was Balzer 's FITC 3, and the secondary Wratten 12. Monochrome 
transparencies were p rin ted from Kodak color slides. Sensitivity of the 
IF procedure fo r detection of ant inuclear ant ibodies was assessed using 
the WHO Internat ional Reference Preparation 66/ 233. Nuclear flu o-
rescence end points corresponded to a potency of 0.625 IU / ml. 
Exp eriments to Bloch Gliadin Binding 
T issue sect ions were preincubated with rabbit anti-human NCRC 
for 30 min prior to incubation with gliadin dissolved in distilled water, 
as described above. 
Absorption with Gliadin 
Patients ' sera dilu ted in P BS were incubated for 1 hr at room 
temperature in gliadin-coated polystyrene tubes (Sarstedt Ltd, UK ), 
coated with an aq ueous suspension of gliadin containing 10 mg/ ml. The 
tubes were cent rifuged at 900 g and the supernatants tested by indirect 
IF on gliadin t reated rat tissue sections. 
ELISA Test 
AGA in patients' sera were detected by the ELISA method [15). 
P lastic Microelisa T rays (Dynatech La boratories Ltd, UK) were coated 
with Flanders crude gliadin (25 J.Lg/ ml in 40% ethanol/water v/ v) . 
Patients' sera were tested at a dilu t ion of 1/ 1000 in PBS conta ining 0.5 
~ T ween 20 (Koch Light Laboratories Ltd) . Peroxidase labeled an ti-
human immunoglobulin (polyvalent) was provided by Dr. P . D. Weston 
(Wellcome Research Laboratories, Beckenham, Kent ) and used at a 
dilut ion of 1/ 10,000. 
RES ULTS 
Binding of Gliadin to Rat and Human Reticulin 
FITC la beled crude gliadin was found to bind to reticulin in 
cryostat sections of normal rat kidney (Fig 1) , liver and stomach 
to give a flu orescent pattern identical to that given by silver 
staining (Fig 2 and 3), by indirect IF using rabbit anti-human 
NCR C or human anti-reticulin antibody. 
Gliadin binding to reticulin fibers in cryostat sections of rat 
tissue was also demonstrated indirectly using rabbit AGA (Fig 
4 and 5). T a ble I shows that only those rabbits with high 
FIG 1. FITC la beled crude gliadin , bound to a cryostat section of a 
rat kidney showing peri tubular fluorescence (X 158). · 
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FIG 2. S ilver impregnation of reticulin fibers in rat liver showing 
marked staining of reticulin fibrils in liver sinusoids (X 252). 
FIG 3. Silver impregnation of reticulin fibers in rat kidney, showing 
peri tubular and periglomerular fibers ( G =glomerulus) (X 252). 
hemagglutination t iters of AGA gave a reticulin staining pattern 
on gliadin pretreated sections. None of our ra bbit antisera to 
gliadin reacted with any of a range of t issue antigens (including 
reticulin) on normal untreated rat or ht,~man t issue. The gliadin 
binding pattern on rat t issue demonstrated indirectly using 
ra bbit AGA was identical to that given directly with FITC 
gliadin, wi th the exception that gliadin binding to sinusoids in 
cryostat sections of rat liver was more pronounced when dem-
onstrated indirectly. 
Gliadin binding to human skin sections was similarly dem-
onstrated by indirect IF. Binding of gliadin to connective t issue 
fibrils in both normal and DH skin was consistently observed, 
and gliadin appeared to be selective for reticulin fibers through-
out the dermis, the collagen bundles remaining unstained. The 
pattern of gliadin binding to rat or human tissue was the same 
with crude gliadin or pure a -gliadin. 
Gliadin binding was not inhibited by pre-incubating t issue 
sections with rabbi t anti-human NCR C. The pattern ·of gliadin 
binding was the same over a range of concentrations of gliadin 
(10- 1 to 10- • mg/ml) in distilled water, but was not detected 
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FIG 4. Reticulin staining pattern , given by rabbit antiserum to glia-
din on a cryostat section of rat kidney treated with crude gliadin 
showing binding of gliadin around the tubules (X 158). 
FIG 5. Reticulin staining pattern given by rabbit antiserum to glia -
din on a cryostat section of liver pretr ea ted with crude gliadin. Binding 
of gliadin to liver sinusoids is clearly seen (X 158). 
TABLE I. Rabbit anti-gliadin sera: Correlation between 
immunofluorescent staining of gliadin treated rat tissue sections 
and anti -gliadin titer determined by passive hemagglutination 
Rabbit 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
Immunofluorescence 
ARA" AGA• 
+ 
+ 
++ 
++ 
++ 
++ 
++ 
++ 
" ARA = anti-reticulin antibody. 
" AGA = antigliad in antibody. 
Hemagglutination 
. AGA 
<1:10 
<1:10 
1:2560 
1:100 
> 1:2560 
> 1:2560 
> 1:2560 
>1:2560 
> 1:2560 
> 1:2560 
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when concentrations of aqueous gliadin of less than w-• mg/ ml 
were used. Gliadin binding could not be demonstrated if tissue 
sections were pretreated with gliadin in PBS or in normal rabbit 
serum (at 10- 1 mg/ml) ra ther than in distilled water. Control 
experiments using distilled water in place of aqueous solutions 
of gliadin gave negative results. 
Comparison of Gliadin Binding, Silver Staining, and 
Staining with Rabbit Anti-Human NCRC on Human Skin 
When the IF pattern of gliadin binding was compared with 
that given by rabbit anti-human NCRC or with the pattern of 
silver staining, some differences were evident. Thus, gliadin 
binding was most striking in the upper dermis and in the dermal 
papillae, where flu orescence was confined to discrete fibrils and 
was also seen immediately below the basement membrane zone 
(BMZ) (Fig 6 and 7). In the lower dermis, gliadin bound to the 
adventitial tissue of blood vessels and to the connective tissue 
associated with skin appendages, while in some areas fluores-
Ft G 6. Cryostat sec tion of DH skin treated with crude gliadin and 
stained indirectly with rabbit anti-gliadin antiserum showing in vitro 
binding of gliadin to fibrils in t he dermis ( X 158). 
FIG 7. Cryostat sec tion of DH skin treated with crude gliadin but 
sta ined with nonimmune rabbit serum to serve as a control (X 252). 
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FIG 8. Staining of reticulin in cryostat section of DH skin using 
rabbit anti-human noncollagenous reticulin component (X 252). 
FIG 9. S ilve r impregnation of reticulin fibrils in a section of normal 
h uman skin. Reticulin fibrils are seen in the upper dermis and in the 
dermal papil.lae ( x 158). 
cent outlining of the negative collagen bundles was also seen. 
By comparison, rabbit anti-human N CRC gave a more diffuse 
staining in the dermal papillae and gave additional fluorescence 
immediately below the BMZ fibrils (Fig 8) . Rabbit anti-human 
NCRC staining of fibrils in the upper dermis and of adventit ial 
tissue of blood vessels throughout the dermis was similar to 
that seen with gliadin. Attempts to define the distribution of 
reticulin fibers in the dermis by silver impregnation indicated 
their presence in t he dermal papillae and immediately below 
· t he BMZ (Fig 9) in human skin. However, silver staining 
appeared to differentiate less satisfactorily between reticulin 
and collagen in the dermis of human skin than in rat liver a nd 
kidney. In one DH skin biopsy, which by chance included a 
longitudinal section of erector pili muscle, the endomysia! con-
nective t issue, although stained by rabbit anti-human NCRC 
(Fig 10), conspicuously failed to bind gliadin (Fig 11) . Similarly, 
in 2 other DH skin biopsies which included recognisable nerve 
fibers, the endoneural connective tissue sheath , although 
brightly stained by rabbit anti-human NCRC, did not bind 
gliadin. 
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c. Comparison of Gliadin Binding to DH and Normal Skin 
The pattern of gliadin binding to DH skin was indistinguish-
able from that seen in normal skin, and was not affected by 
Dapsone treatment of the patients studied, nor by a strict GFD. 
In DH skin, t he pattern of gliadin binding was much more 
extensive than that of in vivo bound IgA and appeared to be 
wholly determined by the distribution of reticulin. In 4 DH skin 
biopsies, a nd in 1 normal skin biopsy, gliadin binding was 
additionally seen at other sites. In 1 DH biopsy, gliadin bound 
to the intercellular substance in the epidermis, giving a pattern 
of staining similar to that seen with pemphigus antibody. In the 
other 4 biopsies weak binding to nuclei of prickle cells in the 
epidermis was noted. 
d . Antibodies in Patients' Sera Reactive with Bound Gliadin 
Serum samples were available from all of the 8 DH patients, 
although not taken at the same time as the biopsy. The patients' 
sera did not agglut inate gliadin coated tanned sheep erythro-
FIG 10. Staining of an erector pili muscle in a cryostat section of 
DH skin by rabbit anti-human noncol.lagenous reticulin component 
(X 252) . 
FIG 11. Cryostat section of DH skin pre-treated with gliad in and 
·tained with rabbit ant i-gliadin; no staining of the reticulin fibrils seen 
in Fig 10. 
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TABLE II. Immunofluorescent (IF) studies on skin biopsy material and serum samples from dermatitis herpeti(ormis (DH) patients 
Patien ts Treatment 
Dapsone 
2 Dapsone 
3 Dapsone 
4 Dapsone 
5 Dapsone 
6 Dapsone 
7 GFD 
8 Remission'' 
IF Studies on DH skin 
Direct IF 
IgA/ C3 
granular 
IgA/ C3 
granular 
IgA/C3 
granular 
IgA/IgM 
linear 
IgA/IgM/C3 
granular 
IgA/ C3 
granular 
IgA/ IgM 
granular 
IgA/ IgM/C3 
granular 
Additional features 
of gliadin binding 
Intercellular cement 
in epidermis; + 
Prickle cell nuclei ; + 
Prickle cell nuclei; + 
Endoneurium; -
Prickle cell nuclei 
+ve, endoneurium; -
Endoneurium; -
Serum antibodies de tected on rat tissue sections 
Autoantibodies 
ARA + 
ANA + 
ANA + 
ANA + 
GPC + 
IF Titer 
1/ 100 
1/200 
l / 400 
1/200 
1/ 1000 
(AGA) 
Reti culin s taining 
pattern on gliadin 
trea ted rat tissue 
+ 
++ 
+ 
IF tite r 
1/400 
1/800 
l/400 
"ARA =Anti-reticulin antibody; AGA =anti-gliadin antibody; ANA= anti-nuclear antibody (titre 1:200 135 IU/ ml); GPC =Gastric parietal 
ce ll antibody. 
" Not currently receiving treatment. 
TABLE III. Anti-gliadin antibodies (AGA) in sera from DH patients 
IF Test on gliadin treated rat tissue 
sections 
Patient Elisa test for AGA" Absorbed 
Unabsorbed with 
Gliadin 
Titer Titer 
1 4% < 1/ 10 < l/10 
2 2% < 1/ 10 <1/10 
3 42% 1/400 1/400 
4 ·o% < 1/ 10 < 1/10 
5 65% l /800 1/200 
6 44% l /400 < 1/10 
7 0% < 1/10 <1/10 
8 0% < 1/10 < 1/10 
"Results expressed as a percentage of a reference serum. Upper limit 
of normal = 5%. 
cytes; serum samples were screened for AGA using the ELISA 
method. AGA were detected in serum samples from patients 3, 
5 and 6 (Table Ill), but were absent or present only in low titre 
in serum from patients 1, 2, 4, 7 and 8, and in serum samples 
from the 5 normal volunteers. The results of autoantibody 
screening and the reactions of these sera on gliadin pre-treated 
cryostat sections of nit tissue are shown in Table II. Pemphigus 
autoantibody was not found in any of the sera, and anti-reticulin 
antibody was present in only 1 DH patient. The sera of 2 DH 
patients negative for anti-reticulin antibody, however, gave a 
reticulin staining pattern on gliadin pretreated sections. These 
2 patients were not on a GFD and had AGA. The serum of the 
DH patient with anti-reticulin antibody gave reticulin pattern 
staining o'f enhanced intensity on a cryostat section of rat tissue 
pre-treated with gliadin; the sera of the other 5 DH patients 
and the 5 normal control subjects gave no reticulin staining on 
gliadin treated sections. 
e. Effect of Absorption with Gliadin (Table Ill) 
The IF staining given on gliadin-treated tissue sections by 
serum from patient 6 was completely abolished by pre-absorp-
tion with gliadin , and that given by serum from patient 5 was 
reduced from 1/800 to 1/ 200 (Table III). The IF staining given 
on gliadin treated tissue sections by serum from patient 3 was 
not affected by pre-absorption with gliadin. The IF titre of 
serum autoantibodies (including ARA) was not affected by pre-
absorption with gliadin. 
DISCUSSION 
We have demonstrated that in aqueous solution, gliadin 
displays a selective affinity for reticulin in cryostat sections of 
rat liver, kidney and stomach. Although we also showed that 
purified a-gliadin binds to reticulin in vitro, we cannot rule out 
the possibility that other gliadin proteins and wheat albumin 
(all of which were present in our crude gliadin preparation) also 
bind to reticulin. Direct staining of rat tissue with FITC labeled 
gliadin, and indirect IF of gliadin treated rat tissue sections 
using rabbit AGA, gave staining patterns almost identical to 
those seen with rabbit anti-human NCRC, with DH patients' 
sera containing anti-reticulin antibody and by silver impregna-
tion, providing good evidence that gliadin binds selectively to 
reticulin fibers on rat tissue sections. Gliadin binding to similar 
fibrils in human skin was also demonstrated although the 
pattern differed in some details from the pattern of skin reticulin 
demonstrated with rabbit anti-human NCRC or silver staining. 
Gliadin binding was not inhibited by rabbit anti-human NCRC, 
but it is possible that antibodies to human NCRC recognise 
different sites on reticulin than those to which gliadin binds. 
Reticulin is known to be a glycoprotein [12], and it is tempting 
to postulate that gliadin binds to reticulin in a lectin-like 
manner, by seeking out sugar residues on reticulin fibers. Bind-
ing of gliadin to the same sugar residues on other glycoproteins 
might account for the minor discrepancies between gliadin 
binding sites in human skin (including the epidermal binding in 
certain biopsies) and the distribution of reticulin as defined by 
anti-human NCRC or silver. Gliadin binding; silver staining 
and specific antibodies such as anti-human NCRC may involve 
similar, but not identical determinants on reticulin fibers. 
It could be postulated that in vivo binding of gliadin to 
reticulin sites in DH skin allows deposition of specific anti-
gliadin antibody, or cross-reacting anti-reticulin antibody, thus 
accounting for the lgA deposits characteristically seen in biop-
sies from the uninvolved skin of DH patients. However, since 
gliadin binding in vitro is also demonstrable on sections of 
normal skin, and in DH skin is not confmed to the dermal 
papillae, additional factors must determine why gluten depen-
dent skin lesions develop only in DH patients. Further, in vivo 
bound deposits of gliadin were not detected in any of the 
biopsies studied. It is possible that in vivo deposits are saturated 
with IgA and rendered inaccessible to the rabbit AGA used to 
demonstrate bound gliadin. Alternatively, om AGA may not 
have included the range of specificity required to detect the 
particular fragment of gluten protein bound in vivo, despite its 
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demonstrable reactivity with Frazer's fraction III, crude gliadin 
and a -gliadin. 
Recent attempts by other workers to demonstrate that glia-
din binds to sites in DH and normal skin were unsuccessful [5, 
18, 19]. We suggest 3 possible reasons for this. First, the gliadin 
preparations they used may have been qualitatively different 
from ours and lacked the component(s) that bind to reticulin. 
Second, since gliadins are insoluble in saline [20], the use of 
such a preparation, or of gliadin in serum, may have been ill-
advised. Indeed we could not demonstrate gliadin binding using 
gliadin in PBS or in neat rabbit serum. Third, the rabbit AGA 
used may not have included the range of specificity crucial for 
recognition of bound gliadin protein. 
Our observation that sera from 2 DH patients (5 and 6) 
(Table II), although negative for ARA, gave a reticulin staining 
pattern when tested on gliadin pre-treated sections, indicates 
that these patients had AGA. 
Further evidence for this was given by absorption studies, 
which demonstrated that the reticulin staining pattern given by 
serum from these 2 patients was lost fo llowing pre-absorption 
with gliadin (Table III). The reticulin staining pattern given by 
serum from patient 3 on untreated rat tissue (titer of 1/ 100) 
was enhanced when retested on gliadin treated sections (titer 
of 1/400), suggesting that AGA as well as ARA were present. 
(Indeed the presence of AGAin serum from patients 3, 5 and 6 
was confirmed by the ELISA method.) However, we were 
unable to reduce the enhanced IF titer of reticulin staining 
given on gliadin treated rat tissue by serum from patient 3 by 
pre-absorption with gliadin. The reason for this is not known. 
Finally, gliadin-treated cryostat sections of rat tissue may 
prove to be of value in screening patients for gluten sensitivity. 
It is important to note, however, that antibody screening by 
indirect IF on such pretreated rat tissue sections does not 
distinguish between ARA and AGA, both of which gave a 
reticulin staining pattern. We report elsewhere encouraging 
results of using such a test in children to exclude a diagnosis of 
gluten sensitive enteropathy. • 
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Milling and Baking Research Association, for helpful discussion, Mr. J. 
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in this study, Dr. W. K. Elstow, Weston Research Laboratories, Taplow, 
Bucks, fo r the Flanders wheat flour and· Dr. P. D. Weston for peroxi-
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